Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)-core prostate biopsy (Q39980615)

16 September 2017

Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)-core prostate biopsy (English)

1 reference

16 September 2017

0 references

Sung Kyu Hong

1

1 reference

16 September 2017

Jong Jin Oh

2

1 reference

16 September 2017

Seok-Soo Byun

3

1 reference

16 September 2017

Sung Il Hwang

4

1 reference

16 September 2017

Hak Jong Lee

5

1 reference

16 September 2017

Gheeyoung Choe

6

1 reference

16 September 2017

Sang Eun Lee

7

1 reference

16 September 2017

language of work or name

1 reference

25 April 2011

1 reference

16 September 2017

1 reference

16 September 2017

72

1 reference

16 September 2017

1

1 reference

16 September 2017

51-57

1 reference

Diabetes mellitus and risk of prostate cancer: a meta-analysis

16 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

The protective effect of diabetes mellitus against prostate cancer: role of sex hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

The association between body size, prostate volume and prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Predictive value of statistical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Prostate cancer risk and serum levels of insulin and leptin: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Insulin resistance and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

The associations of endogenous testosterone and sex hormone-binding globulin with glycosylated hemoglobin levels, in community dwelling men. The Tromsø Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Glycemic control and prostate cancer progression: results from the SEARCH database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Is a decreased serum testosterone level a risk factor for prostate cancer? A cohort study of korean men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21405

21 January 2018

Identifiers

DOI

10.1002/PROS.21405

1 reference

16 September 2017

1 reference